30 abril 2015
Hepatitis C patients who are awaiting a liver transplant or have completed one are a difficult group to cure because hepatitis C can come back after transplant. A recent trial showed that a large number of these patients can be cured with an oral regimen of daclatasvir, sofosbuvir and ribavirin. Treatment was well tolerated with few serious side effects.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/UEKjVdI6TfA/150430134931.htm
